Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “vildagliptin”
Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT06068686. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01159249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
ClinicalTrials.gov study NCT02832999. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
ClinicalTrials.gov study NCT00770081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01219400. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes
ClinicalTrials.gov study NCT01862263. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin Versus Vildagliptin for Diabetic Hypertensive Patients
ClinicalTrials.gov study NCT03253562. IPD Sharing: NO. Countries: 1. Publications: 0.
Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00389415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00633997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers
ClinicalTrials.gov study NCT00419887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy Volunteers
ClinicalTrials.gov study NCT00414947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone
ClinicalTrials.gov study NCT00396357. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk Factors
ClinicalTrials.gov study NCT07077525. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
ClinicalTrials.gov study NCT01910441. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT01559025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00102466. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
ClinicalTrials.gov study NCT03925701. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Vildagliptine and Glimepiride on Glucose Variability
ClinicalTrials.gov study NCT01812122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of Vildagliptin in Early Parkinson's Disease
ClinicalTrials.gov study NCT06951334. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00238498. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.